Felodipine

Product NDC: 0615-6572
11-digit product format: 006156572
Labeler code: 0615
Product ID: 0615-6572_1b5decaf-f1c9-44b7-9b2d-de3fc5b7cc99
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Felodipine
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: NCS HealthCare of KY, Inc dba Vangard Labs
Application: ANDA078855
Marketing category: ANDA
Marketing start: 2009-11-16
Marketing end: 0000-00-00
Substance: FELODIPINE
Active strength: 10 mg/1
Pharmacologic classes: Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0615-6572		D	Discontinued by firm		2026-08-17
excluded package	package	0615-6572	0615-6572-39	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 30 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0615-6572-39	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0615-6572-39	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0615-6572-39	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0615-6572-39	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0615-6572-39	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0615-6572-39	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0615-6572-39	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0615-6572-39	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0615-6572-39	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0615-6572-39	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0615-6572-39	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0615-6572-39	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	0615-6572-39	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	0615-6572-39	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	0615-6572-39	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A078855-001	FELODIPINE	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17
A078855-002	FELODIPINE	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17
A078855-003	FELODIPINE	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078855-002	FELODIPINE	5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078855-003	FELODIPINE	10MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078855-001	FELODIPINE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	2008-04-17	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-09-15 20:21 UTC	2019-09	A078855-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A078855-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A078855-003	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A078855-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A078855-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A078855-003	AB	1	`ea99ee380514…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0615-6572-39	2021-05-12	C162847	48780-1	9d75b9d0-befc-f424-e053-dadaa90a57ce	Felodipine ER Tabs
0615-6572-39	2020-01-31	C162847	48780-1	9d75b9d0-befc-f424-e053-dadaa90a57ce	Felodipine ER Tabs

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
FELODIPINE	ACTIVE INGREDIENT	OL961R6O2C	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
FELODIPINE	ACTIVE MOIETY	OL961R6O2C	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
BUTYLATED HYDROXYANISOLE	INACTIVE INGREDIENT	REK4960K2U	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
SODIUM STEARYL FUMARATE	INACTIVE INGREDIENT	7CV7WJK4UI	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
OL961R6O2C	FELODIPINE	72509-76-3	FELODIPINE

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Felodipine ER Tabs	NCS HealthCare of KY, Inc dba Vangard Labs	2012-10-31	HUMAN PRESCRIPTION DRUG LABEL	2